# FDA WARNING_LETTER - IPR Pharmaceuticals, Inc. - June 10, 2025

Source: https://www.globalkeysolutions.net/records/warning_letter/ipr-pharmaceuticals-inc/814d6d88-7437-49cf-84db-4ac4a311c955

> FDA WARNING_LETTER for IPR Pharmaceuticals, Inc. on June 10, 2025. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: IPR Pharmaceuticals, Inc.
- Inspection Date: 2025-06-10
- Product Type: Drugs
- Office Name: Office of Prescription Drug Promotion

## Related Documents

- [WARNING_LETTER - 2020-08-31](https://www.globalkeysolutions.net/records/warning_letter/ipr-pharmaceuticals-inc/e58d0c86-a64f-401d-9ce2-6051858986cd)
- [CRL - Unknown Date](https://www.globalkeysolutions.net/records/crl/ipr-pharmaceuticals-inc/f3f081b0-7c3c-46f1-b176-7a7d499c5e94)
- [483 - 2018-06-14](https://www.globalkeysolutions.net/records/483/ipr-pharmaceuticals-inc/6167fbc9-2e2d-4eb3-9d94-b1d46f975693)

## Related Officers

- [Director](https://www.globalkeysolutions.net/people/twyla-mosey/1be901d0-b29b-4de7-85fd-a0f2e203e669)

Company: https://www.globalkeysolutions.net/companies/ipr-pharmaceuticals-inc/b4dde979-22da-4c56-93c5-a44a726cff7a

Office: https://www.globalkeysolutions.net/offices/office-of-prescription-drug-promotion/ef9d7ac0-99c5-4b8d-9153-cff47ba23edc